Drug Discovery World

NOVEMBER 29, 2023

The simulator could also be used by pharmaceutical companies to rapidly test multiple drug therapies and patient scenarios, increasing the speed and cost of drug development. The post Mathematical model can speed up Alzheimer’s drug development appeared first on Drug Discovery World (DDW).

Drug Development 130

Drug Development Pharmaceutical Companies Drugs FDA Approval 130

Drug Discovery World

NOVEMBER 3, 2023

First spaceflight mission for drug development lab Redwire will launch its in-space pharmaceutical manufacturing platform, PIL-BOX, onboard SpaceX’s 29th cargo resupply services mission (SpaceX-29) for NASA to the International Space Station (ISS).

Clinical Trials 130

Clinical Trials Drugs Trials Therapies 130

Drug Discovery World

MAY 21, 2024

In contrast, machine learning can facilitate epitope-specific design: directing the algorithm towards favourable epitopes that elicit favourable biological responses, which may improve the prospects for the antibody in drug trials. These targets, along with many others, are universally deemed as ‘difficult-to-drug’ targets.

FDA Approval 147

FDA Approval FDA Disease Treatment 147

Drug Discovery World

FEBRUARY 10, 2023

Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient populations in trials were exposed.

Clinical Trials 130

Clinical Trials Trials Drugs Vaccine 130

Advarra

AUGUST 16, 2022

In 2016, the FDA granted 333 (57%) of the 582 orphan drug designation requests it received – nearly 10 times the number of designations the agency awarded in 1986. The agency’s 2019 guidance, Rare Diseases: Common Issues in Drug Development , called attention to the need for natural history studies for rare diseases.

Disease 52

Disease Clinical Trials FDA Approval FDA 52

PPD

MARCH 28, 2024

In a recent survey of more than 150 global drug development leaders, nearly one in three (30%) cited maximizing asset value/ROI as a top challenge facing their organization — the third-highest reported challenge facing drug developers. PPD Biotech solutions: Your partner for better delivery and capital efficiency.

Trials 52

Trials Clinical Trials Drug Development Clinical Research 52

Drug Discovery World

MARCH 7, 2023

She founded Neuroute in 2019, with the aim of empowering patients from diverse backgrounds to participate in drug trials. Ng studied Neuroscience at University College London and Imperial College London, followed by a stint in academic research in the biotech sector. I owe so much to Franklin and many others.”

International 246

International Science Pharmaceuticals DNA 246